Long-term pituitary downregulation before frozen embryo transfer could improve pregnancy outcomes in women with adenomyosis

References

• Dueholm M. Transvaginal ultrasound for diagnosis of adenomyosis: a review. Best Pract Res Clin Obstet Gynecol 2006;20:569–82
   PubMed Web of Science ®Google Scholar
• Tamai K, Koyama T, Umeoka S, et al. Spectrum of MR features in adenomysosis. Best Pract Res Clin Obstet Gynecol 2006;20:583–602
   PubMed Web of Science ®Google Scholar
• Owolabi TO, Strickler RC. Adenomyosis:an eglected diagnosis. Obstet Gynecol 1977;50:424–7
   PubMed Web of Science ®Google Scholar
• Bird CC, McElin TW, Manolo-Estrella P. The elusive adenomyosis of the uterus-revisited. Am J Obstet Gynecol 1972;112:583–93
   PubMed Web of Science ®Google Scholar
• Vercellini P, Vigano P, Somigliana E, et al. Adenomyosis: epidemiological factors. Best Pract Res Clin Obstet Gynecol 2006;20:465–77
   PubMed Web of Science ®Google Scholar
• Camargo F, Gaytan J, Caligara C, et al. Impact of ultrasound diagnosis of adenomyosis on recipients of sibling oocytes. Fertil Steril 2001;76:S150
   Web of Science ®Google Scholar
• Piver P, Maubon A, Kapella M, et al. Magnetic resonance imaging evaluation of adenomyosis with in IVF patients’ pregnancy rate is linked to measures of junction zone. Fertil Steril 2003;80:S73–4
   Web of Science ®Google Scholar
• Shimizu Y, Fukuda J, Kawamura K, Tanaka T. Retrospectively analysis of the fertility of adenomyosis and the outcome of adenomyosis complicated pregnancy in in vitro fertilization patients. Fertil Steril 2002;77:S50
   Web of Science ®Google Scholar
• Wold AD, Patrizio P, Sepulveda J, et al. The impact of MRI confirmed diagnosis of adenomyosis on the success rates of infertility treatment. Fertil Steril 2005;84:S192–3
   Web of Science ®Google Scholar
• Mijatovic V, Florijn E, Halim N, et al. Adenomyosis has no adverse effects on IVF/ICSI outcomes in women with endometriosis treated with long-term pituitary down-regulation before IVF/ICSI. Eur J Obstet Gynecol Reprod Biol 2010;151:62–5
   PubMed Web of Science ®Google Scholar
• Salim R, Riris S, Saab W, et al. Adenomyosis reduces pregnancy rates in infertile women undergoing IVF. RBM Online 2012;25:273–7
   Google Scholar
• Huang FJ, Kung FT, Chang SY, Hsu TY. Effects of short-course busereline therapy on adenomyosis. J Reprod Med 1999;44:741–4
   PubMed Web of Science ®Google Scholar
• Lin J, Sun C, Zheng H. Gonadotropin-releasing hormone agonists and laparoscopy in the treatment of adenomyosis with infertility. Chin Med J 2000;113:442–5
   PubMed Web of Science ®Google Scholar
• Silva PD, Perkins HE, Schauberger CW. Live birth after treatment of severe adenomyosis with gonadotropin-releasing hormone agonist. Fertil Steril 1994;61:171–2
   PubMed Web of Science ®Google Scholar
• Devlieger R, D’Hooghe Th, Timmerman D. Uterine adenomyosis in the infertility clinic. Hum Reprod Update 2003;9:139–47
   PubMed Web of Science ®Google Scholar
• Dueholm M, Lundorf E. Transvaginal ultrasound or MRI for diagnosis of adenomyosis. Curr Opin Obstet Gynecol 2007;19:505–12
   PubMed Web of Science ®Google Scholar
• Niu Z, Feng Y, Sun Y, et al. Estrogen level monitoring in artificial frozen-thawed embryo transfer cycles using step-up regime without pituitary suppression: is it necessary? J Exp Clin Assist Reprod 2008;5:4--7
   PubMedGoogle Scholar
• Testart J, Lassalle B, Belaisch-Allart J, et al. High pregnancy rate after early human embryo freezing. Fertil Steril 1986;46:268–72
   PubMed Web of Science ®Google Scholar
• Devlieger R, Hooghe T, Dirk T. Uterine adenomyosis in the infertility clinic. Hum Reprod Update 2003;9:139–47
   PubMed Web of Science ®Google Scholar
• Bergholt T, Eriksen L, Berendt N, et al. Prevalence and risk factors of adenomyosis at hysterectomy. Hum Reprod 2001;16:2418–21
   PubMed Web of Science ®Google Scholar
• Dueholm M, Lundorf E, Hansen ES, et al. Magnetic resonance imaging and transvaginal ultrasonography for diagnosis of adenomyosis. Fertil Steril 2001;76:588–94
   PubMed Web of Science ®Google Scholar
• Meredith SM, Sanchez-Ramos L, Kaunitz AM. Diagnostic accuracy of transvaginal sonography for the diagnosis of adenomyosis: systematic review and meta analysis. Am Jobstet Gynecol 2009;201:107.e1–6
   Web of Science ®Google Scholar
• Parrott E, Butterworth M, Green A, et al. Adenomyosis – a result of disordered stromal differentiation. Am J Pathol 2001;159:623–30
   PubMed Web of Science ®Google Scholar
• Levgur M, Abadi MA, Tucker A. Adenomyosis: symptoms, histology, and pregnancy terminations. Obstet Gynecol 2000;95:688–91
   PubMed Web of Science ®Google Scholar
• Brosens JJ, Barker FG, de Souza NM. Myometrial zonal differentiation and uterine junctional zone hyperplasia in the non-pregnant uterus. Hum Reprod Update 1998;4:496–502
   PubMed Web of Science ®Google Scholar
• Kunz G, Leyendecker G. Uterine peristaltic activity during the menstrual cycle: characterization, regulation, function and dysfunction. RBM Online 2002;4:5–9
   Google Scholar
• Hickey M, Fraser I. Human uterine vascular structures in normal and diseased states. Microsc Res Tech 2003;60:377–89
   PubMed Web of Science ®Google Scholar
• Ota H, Tanaka T. Stromal vascularization in the endometrium during adenomyosis. Microsc Res Tech 2003;60:445–9
   PubMed Web of Science ®Google Scholar
• Van Voorhis BJ, Huettner PC, Ckark MR, Hill JA. Immunohistochemical localization of prostaglandin H synthase in the female reproductive tract and endometriosis. Am J Obstet Gynecol 1990;163:57–62
   PubMed Web of Science ®Google Scholar
• Kitawaki J, Noguchi T, Amatsu T, et al. Expression of aromatase cytochrome p450 protain and messenger ribouncleic acid in human endometriotic and adenomyiotic tissues but not in normal endometrium. Biol Reprod 1997;57:514–9
   PubMed Web of Science ®Google Scholar
• Brosens J, Verhoeven H, Campo R. High endometrial aromatase P450 mRNA expression is associated with poor IVF outcome. Hum Reprod 2004;19:352–6
   PubMed Web of Science ®Google Scholar
• Hishihara H, Kitawaki J, Kado N, et al. Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas. Fertil Steril 2003;79:735–42
   PubMed Web of Science ®Google Scholar
• Fischer CP, Kayisili U, Taylor HS. HOXA10 expression is decreased in endometrium of women with adenomyosis. Fertil Steril 2011;95:1133–6
   PubMed Web of Science ®Google Scholar
• Morimoto C, Osuga Y, Yano T, et al. GnRH II as a possible cytostatic regulator in the development of endometriosis. Hum Reprod 2005;20:2312–8
   Web of Science ®Google Scholar
• Limonta P, Moretti RM, Marelli MM, Motta M. The biology of gonadotropin hormone-releasing hormone: role in the control of tumor growth and progression in humans. Front Neuroendocrinol 2003;24:279–95
   PubMed Web of Science ®Google Scholar
• Khan KN, Kitajima M, Hiraki K, et al. Cell proliferation effect of GnRH agonist on pathological lesions of women with endometriosis, adenomyosis and uterine myoma. Hum Reprod 2010;25:2878–90
   PubMed Web of Science ®Google Scholar